Effectiveness of Inhaled Corticosteroids in Controlling Acute Asthma Exacerbations in Children at Home

Abstract

Many clinicians advise their patients to increase the dose of inhaled corticosteroids during acute asthma exacerbations, without strong clinical evidence supporting this treatment. This study investigates the effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. The study population consisted of children with mild intermittent, mild and moderate persistent asthma aged 1 to 14 years who were treated in our outpatient clinic with inhaled budesonide for 1 year. After participating in an asthma education session, the parents were instructed to initiate treatment with inhaled budesonide at the first signs of asthma exacerbation, starting with 200 to 400 pg budesonide, in combination with beta-2 agonists 4 times a day and followed by a decrease in the dose in 4 to 8 days. Asthma status and peak expiratory flow rates were measured in the 3 monthly follow-up visits. Only children who complied with the treatment regimen and came for follow-up visits regularly were included in the final analysis. One hundred fifty children used our treatment protocol with inhaled budesonide to control their asthma attacks. Clinical improvement of asthma symptoms was achieved after a mean of 1.8 +0.7 days from the beginning of treatment. The parents were able to control 94% of the 1,061 episodes of asthma exacerbation occurring during a cumulative follow-up period of 239 years. In the 3-month period before enrollment, 101 children (67%) had used oral corticosteroids to control their asthma attacks and 50 (33%) were hospitalized. During the entire follow-up period, only 11 children (7%) used oral corticosteroids, and none of the children were hospitalized. The present study demonstrates that children with asthma can control their exacerbations at home using inhaled corticosteroids (budesonide). Treatment, starting with relatively high doses followed by a rapid reduction in dose over 4-8 days, resulted in a decrease in the use of oral steroids and in hospitalization. To achieve good results, patient compliance is essential.

Get full access to this article

View all access options for this article.

References

1. Younger RE , Gerber PS , Herrod HG , et al. Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics. 1987;80:225-230.

2. Rowe BH , Keller JL , Oxman AD . Effectiveness of steroid therapy in acute exacerbation of asthma. Am J Emerg Med. 1992;10:301-310.

3. Tal A , Levy N , Berman JE . Methylprednisolone for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics. 1990:350-356.

4. Scarfone RJ , Fuchs SM , Nager AL , et al. Controlled trial of oral prednisone in emergency department treatment of children with acute asthma. Pediatrics. 1993;82:513-516.

5. HarrisJB , Weinberger MM , Nassif E , et al. Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. J Pediatr 1987;110: 627-633.

6. McFadden ER Jr , Kiser R , DeGroot WJ , et al. A controlled study of the effect of single dose of hydrocortisone on the resolution of acute exacerbationss of asthma. Am J Med. 1976;60:52-59.

7. Stein LM , Cole RP . Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med. 1990;112:822-827.

8. Barnett PL , Caputo GL , Baskin M , et al. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med. 1997;29:212-217.

9. Littenberg B , Gluck EH . A controlled trial of methylprednisolone in the emergency treatment of acute asthma. NEnglJ Med. 1986;314:150-152.

10.

10. StorrJ , Barrell E , Barry W , et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987;1:879-881.

11.

11. Global Initiative for Asthma (GINA) guidelines. The pocket guide for physician and nurses (Revised 1998). National Institutes of Health, NIH Publications No. 96-3659B.

12.

12. Toogood JH , Baskerville J , Jennings BA , et al. Bioequivalent dose of budesonide and prednisolone in moderate and severe asthma. J Allergy Clin Immunol. 1989;84:688-700.

13.

13. Levy ML , Stevevson C , Maslen T. Comparisone of short courses of oral prednisolone and fluticasone propionate in treatment of adults with acute exacerbation of asthma in primary care. Thorax. 1966;51:1087-1092.

14.

14. Volovitz B , Amir J , Malik H , et al. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N EnglJ Med. 1993;329:1703-1708.

15.

15. Engel T , Dirksen A , HeiningJH , et al. Single-dose inhaled budesonide in subjects with chronic asthma. Allergy. 1991;46:547-553.

16.

16. Connet G , Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child. 1993;68:85-87.

17.

17. SvedmyrJ , Nyberg E , Asbrink-Nilsson E , et al. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections. Acta Paediatr 1995;84:884-888.

18.

18. Wilson NM , Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 1990;65:407-410.

19.

19. GarrettJ , Williams S , Wong C , et al. Treatment of acute asthmatic attacks with an increased dose of inhaled steroid. Arch Dis Child. 1998;79:12-17.

20.

20. Volovitz B , Soferman R , Blau H , et al. Rapid induction of clinical response with a short-term high-dose startingschedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J Allergy Clin Immunol. 1998;101:464-469.

21.

21. Volovitz B , Bentur L , Finkelstein Y , et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children. A controlled study compared to oral prednisolone in the emergency department. J Allergy Clin Immunol. 1998;102:605-609.

22.

22. GarrettJ , Wlliams S , Wong C , et al. Application of asthma action plan to childhood asthma: a national survay. NZMedj 1997;110:308-310.

23.

23. Doull IJM , Lampe FC , Smith S , et al. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomized double-blind placebocontrolled trial. Br Med J. 1997;315:858-862.

24.

24. Glanz K , Field SB , Swartz MA , et al. Compliance with an experimental drug regimen for treatment of asthma: its magnitude, importance, and correlates. J Chron Dis. 1984;37:815-824.

25.

25. De Blic J , Delacourt C , Le Bourgeois M , et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study. JAIlergy Clin Immunol. 1996;98:14-20.

26.

26. Wennergren G , Nordvall SL , Hedlin G , et al. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Pediatr 1996;85:183-189.

27.

27. Tal A , Golan H , Grauer N , et al. Deposition pattern of radio labeled salbutamol, inhaled from a metereddose inhaler by means of a spacer with mask, in children with airway obstruction. J Pediatr 1996;128:479-484.

28.

28. Thorsson L , Edsbacker S , Coradson TB . Lung deposition of budesonide from turbohaler is twice that from pressurized metered-dose inhaler P MDI. EurRespirj 1994;7:1839-1844.